InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
50%
T+90 mean return
-14.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by San Martin Javier, Directeur Médical. Director active across 3 companies, notably Arrowhead Pharmaceuticals, INC.. Cumulatively, 10 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.8m. Activity tracked since 19 November 2021. The latest transaction was disclosed on 3 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to San Martin Javier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
7,418 shares0Common StockSEC:0001794629-26-000004:0
4,667 shares0Common StockSEC:0001794629-26-000002:0
46,666 shares0Common StockSEC:0001415889-25-019068:0
46,667 shares0Common StockSEC:0001415889-25-000544:0
75,000 shares0Common StockSEC:0001628280-24-000865:0
14,758 shares@ US$28.7314.8% of flowCommon StockSEC:0001628280-23-039850:0
60,000 shares0Common StockSEC:0001209191-23-002119:0
19,300 shares@ US$29.9821.4% of flowCOMMON STOCKSEC:0001209191-22-058469:0
200 shares@ US$30.620.2% of flowCOMMON STOCKSEC:0001209191-22-058469:1
13,704 shares@ US$69.010.0077% mcap50.0% of flowCommon StockSEC:0001209191-21-066123:0
10 of 10 declarations
About San Martin Javier
Javier San Martin is the Chief Medical Officer of ARROWHEAD PHARMACEUTICALS, INC. He is responsible for medical leadership and innovation in the development of new treatments. His expertise is essential in ensuring the quality and effectiveness of the company's products.
